As Minnesota insurers limit access to hepatitis C drugs, patients chafe

As Minnesota insurers limit access to hepatitis C drugs, patients chafe RENÉE JONES SCHNEIDER • reneejones@startribune.com Kelly Krodel, right, was diagnosed with hepatitis C soon after her daughter Maddie was born. Because she is healthy, two insurers have denied coverage … Continue reading

'Specialty drugs' making up larger percentage of prescription costs

'Specialty drugs' making up larger percentage of prescription costs The hepatitis C virus is most commonly spread by blood contact such as sharing needles for drug use, or inadvertent needle sticks injuring providers treating patients. What complicates the cost-vs.-treatment equation … Continue reading